To validate the system, we transfected the reporter plasmid into MCF-7 (ER positive/HER2 negative), BT474 (ER positive/HER2 positive), and MDA-MB-453 (ER negative/HER2 positive) breast cancer cell lines. Here, ERBB2 is linked to breast cancer.